Erkorkmaz, Ünal
(TUBITAK SCIENTIFIC & TECHNICAL RESEARCH COUNCIL, 2010)
Conclusion: This study demonstrated that 1% CAPE was as clinically efficacious as 0 1% olopatadine and 0 1% dexamethasone. Thus, 1% CAPE may be an alternative to 0 1% olopatadine and 0 1% dexamethasone in the management ...